Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 388-392

  Otto, Tamara C ^a   Kasten, Shane A ^a   Kovaleva, Elena ^b   Liu, Zhi ^b   Buchman, George ^b   Tolosa, Marita ^b   Davis, David ^b   Smith, J Richard ^a   Balcerzak, Robert ^b   Lenz, David E ^a   Cerasoli, Douglas M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b Chesapeake PERL Inc ^*  (United States)

Author keywords

Catalytic bioscavenger; Nerve agent; Organophosphorus

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHLORPYRIFOS; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; RECOMBINANT ENZYME;

ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CATERPILLAR; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME PURIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOTH; NONHUMAN; PEPTIDE MAPPING; PESTICIDE RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

HEXAPODA; LEPIDOPTERA; TRICHOPLUSIA NI;

EID: 77955510776     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.02.022     Document Type: Article

References (14)

1. Taylor P. Anticholinesterase agents. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001, 175-192. McGraw-Hill, New York. J.G. Hardman, L.E. Limbird, A.G. Gilman (Eds.).
2. Maynard R.L., Beswick F.W. Organophosphorus compounds as chemical warfare agents. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 373-385. Butterworth, Oxford, London. B. Ballantyne, T.C. Marrs (Eds.).
3. Otto T.C., Harsch C.K., Yeung D.T., Magliery T.J., Cerasoli D.M., Lenz D.E. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. Biochemistry 2009, 48(43):10416-10422.
4. Yeung D.T., Smith J.R., Sweeney R.E., Lenz D.E., Cerasoli D.M. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase. FEBS J. 2007, 274(5):1183-1191.
5. Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C., La Du B.N. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 2000, 28(11):1335-1342.
6. Rodrigo L., Mackness B., Durrington P.N., Hernandez A., Mackness M.I. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem. J. 2001, 354(Pt 1):1-7.
7. Gaidukov L., Rosenblat M., Aviram M., Tawfik D.S. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, stimulation of lipo-lactonase, and macrophage cholesterol efflux. J. Lipid Res. 2006, 47(11):2492-2502.
8. Stevens R.C, Suzuki S.M., Cole T.B., Park S.S., Richter R.J., Furlong C.E. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(35):12780-12784.
9. Aharoni A., Gaidukov L., Yagur S., Toker L., Silman I., Tawfik D.S. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(2):482-487.
10. Welch R.W., Campbell J., Toledo A., Davis D., Latzgo H., Haupt G., Love G., Sly J.M., Cohen G., Eisenberg R., Whitbeck J.C., Aldaz-Carroll L., Lou H., Lenz D.E., Patel P.C., Cerasoli D. Rapid production of recombinant proteins utilizing the PERLXpress platform. BioProcess. J. 2006, 5:63-70.
11. Liu Y., DeCarolis N., Beek N. Protein production with recombinant baculoviruses in lepidopteran larvae. Methods Mol. Biol. 2007, 388:267-280.
12. Smith J.R. Analysis of the enantiomers of VX using normal-phase chiral liquid chromatography with atmospheric pressure chemical ionization-mass spectrometry. J. Anal. Toxicol. 2004, 28(5):390-392.
13. van der Schans M.J., Lander B.J., van der W.H., Langenberg J.P., Benschop H.P. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 2003, 191(1):48-62.
14. Furlong C.E., Richter R.J., Seidel S.L., Costa L.G., Motulsky A.G. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal. Biochem. 1989, 180(2):242-247.